+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
From
Multiple Myeloma Drugs Market 2023-2027 - Product Thumbnail Image

Multiple Myeloma Drugs Market 2023-2027

  • Report
  • October 2022
  • 120 Pages
  • Global
From
Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022 - Product Thumbnail Image

Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022

  • Clinical Trials
  • November 2022
  • 80 Pages
  • Global
From
From
From
From
From
Chronic Kidney Disease Global Market Report 2024 - Product Thumbnail Image

Chronic Kidney Disease Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Kidney Disease Global Market Report 2024 - Product Thumbnail Image

Kidney Disease Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Market Spotlight: Psoriatic Arthritis - Product Thumbnail Image

Market Spotlight: Psoriatic Arthritis

  • Report
  • September 2020
  • 65 Pages
  • Global
From
The Biosimilars Landscape in Japan: 2009-2020 Study - Product Thumbnail Image

The Biosimilars Landscape in Japan: 2009-2020 Study

  • Report
  • January 2020
  • 156 Pages
  • Japan
From
From
Loading Indicator